Naloxone
Specifications
465-65-6CAS Number
207-365-7EC Number
(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-oneIUPAC Name
C19H21NO4Chemical Formula
327.4 g/molMolecular Weight
naloxone; 465-65-6; l-Naloxone; (-)-Naloxone; n-Allylnoroxymorphone; Naloxona; EN 1530 base; Naloxonum; Nalossone; N-Allyl-noroxymorphone; DBL Naloxone; 1-N-Allyl-14-hydroxynordihydromorphinone; Naloxone Nasal Spray; 17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one; DTXSID8023349; 1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone; l-N-Allyl-14-hydroxynordihydromorphinone; NSC-70413; 17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one; l-N-Allyl-7,8-dihydro-14-hydroxynormorphinone; 36B82AMQ7N; CHEBI:7459; N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon; 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone; Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-; Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-; Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-; 17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one; Normorphinone, N-allyl-7,8-dihydro-14-hydroxy-, (-)-; DTXCID703349; (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one; Morphinan-6-one, 4,5-alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-; (1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one; Abello, Naloxone; Curamed, Naloxon; Naloxon ratiopharm; (1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7(18),8,10-trien-14-one; (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinolin-7-one; naloxoni hydrochloridum; Hydrobromide, Naloxone; RefChem:6051; MRZ 2593Br; MRZ 2593 Br; MRZ 2593-Br; A06AH04; Dihydride, Naloxone Hydrochloride; Hydrochloride Dihydride, Naloxone; MRZ2593; V03AB15; MRZ 2593; (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinoline-7-one; 207-365-7; Narcan; Nalossone [DCIT]; Naloxonum [INN-Latin]; Naloxona [INN-Spanish]; Nalone; HSDB 3279; Naloxone (INN); NIOSH/QD2135000; RAM-301; A1APV; Narcon; NALOXONE [INN]; 7,8-Dihydro-N-allyl-14-hydroxynormorphinone; Naloxone [INN:BAN]; NSC 70413; QD21350000; Normorphinone, 7,8-dihydro-N-allyl-14-hydroxy-; 17-Allyl-3,14-dihydroxy-4,5-alpha-epoxymorphinan-6-one; Morphinan-6-one, 17-allyl-3,14-dihydroxy-4,5-alpha-epoxy-; MLS000069540; [3H]naloxone; CAS-465-65-6; MLS000736771; SMR000058766; EINECS 207-365-7; BRN 1089071; UNII-36B82AMQ7N; Nyxoid; [N-allyl-2,3-3H]naloxone; NCGC00162267-02; Normorphinone, N-allyl-dihydro-14-hydroxy-; NALOXONE [HSDB]; NALOXONE [MI]; CHEMBL80; NALOXONE [VANDF]; Prestwick0_000111; Prestwick1_000111; Prestwick2_000111; Prestwick3_000111; (5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one; Epitope ID:549277; NALOXONE [USP-RS]; NALOXONE [WHO-DD]; NALOXONE [EMA EPAR]; SCHEMBL34284; BSPBio_000122; (-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one; BIDD:GT0110; SPBio_002061; NALOXONE [ORANGE BOOK]; BPBio1_000136; GTPL1638; GTPL1676; SCHEMBL29427581; BDBM54795; cid_5464092; Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-; BDBM579486; HMS2090F20; US11484525, Compound Naloxone; Tox21_112006; 3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one; BDBM50000788; EBC-26597; HY-17417A; PDSP2_001520; (5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one; AKOS016009988; Tox21_112006_1; DB01183; FN61467; SMP1_000205; NCGC00024674-02; NCGC00024674-03; NCGC00024674-14; NCGC00274058-01; 12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one; DA-65917; 4683B; CS-0012343; Kloxxado (naloxone hydrochloride nasal spray); NS00002914; C07252; D08249; H55415; EN300-19748912; Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-; Q282902; (-)-N-ALLYL-14-HYDROXYNORDIHYDROMORPHINONE; BRD-K67511046-001-02-3; BRD-K67511046-003-03-7; BRD-K67511046-003-14-4; BRD-K67511046-003-15-1; BRD-K67511046-003-16-9; 17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE; (5?)-3,14-Dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one; Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy- (8CI); Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-17-(2-propenyl)-; [17-(2,3-3H-2-propenyl)]-4, 5a -epoxy-3,14-dihydroxymorphinan-6-one; 3,14-Dihydroxy-17-(prop-2-en-1-yl)-5alpha-4,5-epoxymorphinan-6-one; MORPHINAN-6-ONE, 4,5-EPOXY-3,14-DIHYDROXY-17-(2-PROPENYL)-; Morphinan-6-one,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-; 4aH-8,5-bcd]furan-5(6H)-one, N-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-; Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- (9CI); (4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride; (4R,4aS,7aR,12bS)-4a,9-bis(oxidanyl)-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride; (4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride; (naloxone) 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one; (naloxone)4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one; (naloxone)4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one; 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one; 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one (naloxone); 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one( Naloxone); 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(Naxolone); 4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one; 4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(naloxone)C2H2O4Synonyms
